Natacha Maillard

1.6k total citations
31 papers, 409 citations indexed

About

Natacha Maillard is a scholar working on Hematology, Genetics and Oncology. According to data from OpenAlex, Natacha Maillard has authored 31 papers receiving a total of 409 indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Hematology, 9 papers in Genetics and 8 papers in Oncology. Recurrent topics in Natacha Maillard's work include Hematopoietic Stem Cell Transplantation (19 papers), Acute Myeloid Leukemia Research (13 papers) and Chronic Myeloid Leukemia Treatments (8 papers). Natacha Maillard is often cited by papers focused on Hematopoietic Stem Cell Transplantation (19 papers), Acute Myeloid Leukemia Research (13 papers) and Chronic Myeloid Leukemia Treatments (8 papers). Natacha Maillard collaborates with scholars based in France, Netherlands and United Kingdom. Natacha Maillard's co-authors include Ibrahim Yakoub‐Agha, Régis Peffault de Latour, Gèrard Socié, Marie Robin, Patrice Chevallier, Agnès Buzyn, Abdellatif Tazi, Anne Bergeron, Ioannis A. Voutsadakis and Cendrine Godet and has published in prestigious journals such as Blood, American Journal of Respiratory and Critical Care Medicine and Cancer.

In The Last Decade

Natacha Maillard

30 papers receiving 404 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Natacha Maillard France	12	286	109	86	68	67	31	409
Michihiro Uchiyama Japan	9	276 1.0×	117 1.1×	107 1.2×	56 0.8×	45 0.7×	41	420
Carla Filì Italy	10	310 1.1×	52 0.5×	63 0.7×	28 0.4×	44 0.7×	24	436
Masanobu Morioka Japan	11	129 0.5×	73 0.7×	44 0.5×	50 0.7×	36 0.5×	64	329
Kyoo Hyung Lee South Korea	11	182 0.6×	116 1.1×	48 0.6×	51 0.8×	28 0.4×	44	405
C. Filì Italy	6	215 0.8×	63 0.6×	40 0.5×	57 0.8×	79 1.2×	9	326
Byoung Kook Kim South Korea	12	192 0.7×	135 1.2×	61 0.7×	36 0.5×	33 0.5×	43	410
Sinem Civriz Bozdağ Türkiye	10	214 0.7×	114 1.0×	76 0.9×	27 0.4×	19 0.3×	61	397
Seçkin Çağırgan Türkiye	9	187 0.7×	67 0.6×	58 0.7×	33 0.5×	30 0.4×	45	329
B M Camitta United States	6	293 1.0×	88 0.8×	74 0.9×	39 0.6×	44 0.7×	10	413
Olga Militano United States	12	247 0.9×	176 1.6×	55 0.6×	25 0.4×	27 0.4×	42	446

Countries citing papers authored by Natacha Maillard

Since Specialization

Citations

This map shows the geographic impact of Natacha Maillard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Natacha Maillard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Natacha Maillard more than expected).

Fields of papers citing papers by Natacha Maillard

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Natacha Maillard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Natacha Maillard. The network helps show where Natacha Maillard may publish in the future.

Co-authorship network of co-authors of Natacha Maillard

This figure shows the co-authorship network connecting the top 25 collaborators of Natacha Maillard. A scholar is included among the top collaborators of Natacha Maillard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Natacha Maillard. Natacha Maillard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Michonneau, David, Florent Malard, Léonardo Magro, et al.. (2025). Efficacy and safety of belumosudil for treatment of cGVHD: multicenter retrospective analysis of the French cohort of the compassionate use program, on behalf of the French Society of Bone Marrow Transplantation and Cellular Therapy. Bone Marrow Transplantation. 60(6). 779–786. 4 indexed citations

Chevallier, Patrice, Anne C. M. Thiébaut, Sylvie François, et al.. (2025). A phase II study of ponatinib for prevention of relapse after allotransplantation in <i>FLT3</i> internal tandem duplication mutation positive (FLT3-ITD+) acute myeloid leukemia: the PONALLO trial. Haematologica. 110(10). 2525–2529. 1 indexed citations

Forcade, Édouard, Marie Robin, Marie‐Thérèse Rubio, et al.. (2024). IDALLO study: A retrospective multicenter study of the SFGM‐TC evaluating the efficacy and safety of ivosidenib in relapsed IDH1‐mutated AML after allogeneic hematopoietic cell transplantation. HemaSphere. 8(3). e44–e44.

Nagler, Arnon, Myriam Labopin, Alexander Kulagin, et al.. (2023). Long-term outcome of second allogeneic hematopoietic stem cell transplantation (HSCT2) for primary graft failure in patients with acute leukemia in remission: A study on behalf of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation. Bone Marrow Transplantation. 58(9). 1008–1016. 4 indexed citations

Chomel, Jean‐Claude, et al.. (2023). Combination of azacitidine, venetoclax and ruxolitinib in blast phase myeloproliferative neoplasms. British Journal of Haematology. 202(2). 284–288. 3 indexed citations

Chevallier, Patrice, Sylvie François, Sylvain Chantepie, et al.. (2023). A Phase 2 Study of Ponatinib for Prevention of Relapse after Allotransplantation in FLT3-ITD + AML Patients : The Ponallo Trial. Blood. 142(Supplement 1). 4957–4957. 1 indexed citations

Mannone, Lionel, Yves Chalandon, Patrice Chevallier, et al.. (2019). Allogeneic Stem Cell Transplantation in Therapy-Related Myelodysplasia after Autologous Transplantation for Lymphoma: A Retrospective Study of the Francophone Society of Bone Marrow Transplantation and Cellular Therapy. Biology of Blood and Marrow Transplantation. 25(12). 2366–2374. 3 indexed citations

Robinson, Stephen, Ariane Boumendil, Karl S. Peggs, et al.. (2018). Long-term outcome analysis of reduced-intensity allogeneic stem cell transplantation in patients with mantle cell lymphoma: a retrospective study from the EBMT Lymphoma Working Party. Bone Marrow Transplantation. 53(5). 617–624. 34 indexed citations

Lengliné, Étienne, Bernard Drénou, Pierre Péterlin, et al.. (2017). Nationwide survey on the use of eltrombopag in patients with severe aplastic anemia: a report on behalf of the French Reference Center for Aplastic Anemia. Haematologica. 103(2). 212–220. 45 indexed citations

10.

Bergeron, Anne, Sylvie Chevret, Karine Chagnon, et al.. (2015). Budesonide/Formoterol for Bronchiolitis Obliterans after Hematopoietic Stem Cell Transplantation. American Journal of Respiratory and Critical Care Medicine. 191(11). 1242–1249. 64 indexed citations

11.

Cornillon, Jérôme, Annalisa Ruggeri, Patrice Chevallier, et al.. (2015). Outcomes of Cord Blood Transplantation Using Reduced-Intensity Conditioning for Chronic Lymphocytic Leukemia: A Study on Behalf of Eurocord and Cord Blood Committee of Cellular Therapy and Immunobiology Working Party, Chronic Malignancies Working Party of the European Society for Blood and Marrow Transplantation, and the Societé Française de Greffe de Moelle et Therapie Cellulaire. Biology of Blood and Marrow Transplantation. 21(8). 1515–1523. 7 indexed citations

12.

Cabrespine, Aurélie, Gèrard Socié, Nöel Milpied, et al.. (2015). Impact of Thymoglobulin by Stem Cell Source (Peripheral Blood Stem Cell or Bone Marrow) After Myeloablative Stem Cell Transplantation From HLA 10/10-Matched Unrelated Donors. Transplantation. 100(8). 1732–1739. 11 indexed citations

13.

Godet, Cendrine, Jérôme Le Goff, Agnès Beby‐Defaux, et al.. (2014). Human metapneumovirus pneumonia in patients with hematological malignancies. Journal of Clinical Virology. 61(4). 593–596. 23 indexed citations

14.

Vantyghem, Marie‐Christine, Jérôme Cornillon, Christine Decanter, et al.. (2014). Management of endocrino-metabolic dysfunctions after allogeneic hematopoietic stem cell transplantation. Orphanet Journal of Rare Diseases. 9(1). 162–162. 27 indexed citations

15.

Cabrespine, Aurélie, Gèrard Socié, Nöel Milpied, et al.. (2014). Peripheral Blood Stem Cells Vs Bone Marrow: Stem Cell Source Comparison for Patients Acute Myeloid Leukemia and Myelodysplastic Syndrome Receiving an Allogeneic Stem Cell Transplantation from a 10/10 Matched Donor. Study from the French Society of Bone Marrow Transplantation and Cell Therapies (SFGM-TC). Blood. 124(21). 2552–2552. 1 indexed citations

16.

Réa, Delphine, Oumédaly Reman, Natacha Maillard, et al.. (2010). Impact of Prior Second-Generation Tyrosine Kinase Inhibitors on the Outcome of Hematopoietic Stem Cell Transplantation for Chronic Myeloid Leukemia. Blood. 116(21). 2267–2267. 1 indexed citations

17.

Ghez, David, Marie Thérèse Rubio, Natacha Maillard, et al.. (2009). Rapamycin for Refractory Acute Graft-Versus-Host Disease. Transplantation. 88(9). 1081–1087. 25 indexed citations

18.

Voutsadakis, Ioannis A. & Natacha Maillard. (2003). Acute myelogenous leukemia with the t(3;12)(q26;p13) translocation: Case report and review of the literature. American Journal of Hematology. 72(2). 135–137. 11 indexed citations

19.

Lefrère, François, Richard Delarue, Dominique Somme, et al.. (2002). High‐dose CD34+ cells are not clinically relevant in reducing cytopenia and blood component consumption following myeloablative therapy and peripheral blood progenitor cell transplantation as compared with standard dose. Transfusion. 42(4). 443–450. 9 indexed citations

20.

Maillard, Natacha, Pascal Foucher, D. Caillot, et al.. (1999). Transient Pulmonary Infiltrates during Treatment with Anti-Thymocyte Globulin. Respiration. 66(3). 279–282. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact